May serum advanced oxidation protein products levels be diagnostic markers in endometrioma?
Serum levels of AOPP, calprotectin, CA 125, and CA19-9 may serve as predictive biomarkers for endometrioma. However, further studies with larger sample sizes are needed to validate these findings and confirm the diagnostic utility of these biomarkers in clinical practice.
Authors
- Özlem Moraloğlu Tekın (ORCID: https://orcid.org/0000-0001-8167-3837)
- Nazan Vanlı Tonyalı (ORCID: https://orcid.org/0000-0002-7284-6887)
- Dilara Duygulu Bulan (ORCID: https://orcid.org/0000-0001-9983-2306)
- Ruken Dayanan (ORCID: https://orcid.org/0000-0002-8192-8841)
- Aytekin Tokmak (ORCID: https://orcid.org/0000-0001-5739-5689)
- Rıfat Taner Aksoy (ORCID: https://orcid.org/0000-0003-3931-4835)
- Arzu Kösem (ORCID: https://orcid.org/0000-0002-6213-1749)
- Mehmet Çınar (ORCID: https://orcid.org/0000-0003-1607-2343)
- Melike Doğanay (ORCID: https://orcid.org/0000-0002-2603-1812)
Institutions
- Bilkent University (TR)
- Memorial Ankara Hospital (TR)
- Ankara Bilkent City Hospital (TR)
- Mersin Üniversitesi (TR)
Publication Details
- Journal
- BMC Women s Health
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1186/s12905-025-04145-9
- Primary Topic
- Endometriosis Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00